Smith Drug, PerceptiMed announce distributorship agreement
Smith Drug Co. has entered into a non-exclusive agreement to distribute the PerceptiMed, scripClip will-call system to pharmacies.
Pharmacy
PBMs support transparency for consumers, health plan sponsors, policymakers
The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-
PCMA issues statement on proposed Rx drug rebate rule
Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Ame
Walgreens, Kaléo expand pharmacy program
Walgreens and Kaléo announced Thursday AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S.
Kroger Health teams up to launch depression treatment pilot
Kroger Health, the healthcare arm of The Kroger Co., announced its partnership with Myriad Genetics to pilot Myriad Genetics’ GeneSight pharmacogenomic test with Kroger Prescription Plan members. Nearly 500 Kroger pharmacies across five states will participate in the GeneSight pilot.
Dr. Reddy’s releases O-T-C store brand equivalent of Mucinex D extended release tablets
Dr. Reddy’s announced launch of an over-the-counter (O-T-C) store-brand equivalent of Mucinex D Extended Release Tablets in two strengths— guaifenesin 600 mg and pseudoephedrine HCl 60 mg, and guaifenesin 1200 mg and pseudoephedrine HCl 120 mg—in the United States market, as approved by the U.S.
Lilly reports new data indicating rise in opioid use for migraine treatment
Eli Lilly and Co. announced the upcoming presentation of data indicating rising rates of opioid use for the treatment of migraine based on results from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine) study.
Sandstone Pharmacies to invest in nine more scripClip systems
PerceptiMed, the makers of the scripClip pick-to-light will call system announced Wednesday that Sandstone Pharmacies, of Calgary, Alberta, Canada have agreed to install the system in nine more of their pharmacies.
CVS expands safe medication disposal program in Ohio
CVS Pharmacy announced Wednesday the expansion of its safe medication disposal program in Ohio, adding disposal units in 53 CVS Pharmacy stores in communities across the state, including Cincinnati, Cleveland, Columbus, Dayton, Toledo and Youngstown.
MinuteClinic rolls out Virtual Visits in more states
CVS Health announced Wednesday that MinuteClinic, the company’s retail medical clinic, has rolled out its virtual visit offering in eight additional states.
IngenioRx joins the Pharmaceutical Care Management Association
The Pharmaceutical Care Management Association (PCMA) is announcing the addition of IngenioRx as its newest member company. IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc.
Aon hires Matt Gibbs to lead pharmacy solutions practice
CHICAGO – Aon announced Monday that Matt Gibbs was hired to lead the firm’s growing pharmacy solutions practice. As Aon’s senior vice president, pharmacy solutions leader, Gibbs will manage a team that serves employers across the U.S.
Pharmacists for Healthier Lives issues statement on vaccinations
a coalition of pharmacy organizations seeking to raise consumer awareness of the full range of essential healthcare services pharmacists provide each day — Monday released a statement expressing the coalition’s commitment to immunizations that help to prevent and eliminate communicable diseases such
OmniSYS acquires Strand Clinical Technologies
OmniSYS, a technology company focused on innovative solutions for the retail pharmacy industry, announced Monday that it has acquired Strand Clinical Technologies. Strand helps retail pharmacists launch and support clinical services within their community.
Upsher-Smith to commercialize Klor-Con and Potassium Chloride product families
Upsher-Smith announced that effective July 1, 2019 it will commercialize the Klor-Con (potassium chloride) and Potassium Chloride product families and will continue its role as manufacturer.